| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Neuroscience Program and 3 Department of Cell and Structural Biology, University of Illinois at Urbana-Champaign, Urbana 61801; and 2 Department of Pharmacology and Biological Chemistry and Northwestern Drug Discovery Program, Northwestern University Medical School, Chicago, Illinois 60611
The aim of this study was to identify the melatonin receptor type(s) (MT1 or MT2) mediating circadian clock resetting by melatonin in the mammalian suprachiasmatic nucleus (SCN). Quantitative receptor autoradiography with 2-[125I]iodomelatonin and in situ hybridization histochemistry, with either 33P- or digoxigenin-labeled antisense MT1 and MT2 melatonin receptor mRNA oligonucleotide probes, revealed specific expression of both melatonin receptor types in the SCN of inbred Long-Evans rats. The melatonin receptor type mediating phase advances of the circadian rhythm of neuronal firing rate in the SCN slice was assessed using competitive melatonin receptor antagonists, the MT1/MT2 nonselective luzindole and the MT2-selective 4-phenyl-2-propionamidotetraline (4P-PDOT). Luzindole and 4P-PDOT (1 nM-1 µM) did not affect circadian phase on their own; however, they blocked both the phase advances (~4 h) in the neuronal firing rate induced by melatonin (3 pM) at temporally distinct times of day [i.e., subjective dusk, circadian time (CT) 10; and dawn, CT 23], as well as the associated increases in protein kinase C activity. We conclude that melatonin mediates phase advances of the SCN circadian clock at both dusk and dawn via activation of MT2 melatonin receptor signaling.
suprachiasmatic nucleus; brain slice electrophysiology; luzindole; 4-phenyl-2-propionamidotetraline; protein kinase C
This article has been cited by other articles:
|
|
 |
|
  V. Srinivasan, D W. Spence, S. R. Pandi-Perumal, I. Trakht, and D. P. Cardinali Therapeutic Actions of Melatonin in Cancer: Possible Mechanisms Integr Cancer Ther, September 1, 2008; 7(3): 189 - 203. [Abstract] [PDF]
|
|
|
|
 |
|
 M. I. Masana, I. C. Sumaya, M. Becker-Andre, and M. L. Dubocovich Behavioral characterization and modulation of circadian rhythms by light and melatonin in C3H/HeN mice homozygous for the RORbeta knockout Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2007; 292(6): R2357 - R2367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Blask, G. C. Brainard, R. T. Dauchy, J. P. Hanifin, L. K. Davidson, J. A. Krause, L. A. Sauer, M. A. Rivera-Bermudez, M. L. Dubocovich, S. A. Jasser, et al. Melatonin-Depleted Blood from Premenopausal Women Exposed to Light at Night Stimulates Growth of Human Breast Cancer Xenografts in Nude Rats Cancer Res., December 1, 2005; 65(23): 11174 - 11184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hirai, M. Kita, H. Ohta, H. Nishikawa, Y. Fujiwara, S. Ohkawa, and M. Miyamoto Ramelteon (TAK-375) Accelerates Reentrainment of Circadian Rhythm after a Phase Advance of the Light-Dark Cycle in Rats J Biol Rhythms, February 1, 2005; 20(1): 27 - 37. [Abstract] [PDF]
|
|
|
|
 |
|
 S. M. W Rajaratnam, B. Middleton, B. M Stone, J. Arendt, and D.-J. Dijk Melatonin advances the circadian timing of EEG sleep and directly facilitates sleep without altering its duration in extended sleep opportunities in humans J. Physiol., November 15, 2004; 561(1): 339 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Soares Jr., M. I. Masana, C. Ersahin, and M. L. Dubocovich Functional Melatonin Receptors in Rat Ovaries at Various Stages of the Estrous Cycle J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 694 - 702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Gerdin, M. I. Masana, D. Ren, R. J. Miller, and M. L. Dubocovich Short-Term Exposure to Melatonin Differentially Affects the Functional Sensitivity and Trafficking of the hMT1 and hMT2 Melatonin Receptors J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 931 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Mutoh, S. Shibata, H.-W. Korf, and H. Okamura Melatonin modulates the light-induced sympathoexcitation and vagal suppression with participation of the suprachiasmatic nucleus in mice J. Physiol., February 15, 2003; 547(1): 317 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Jin, C. von Gall, R. L. Pieschl, V. K. Gribkoff, J. H. Stehle, S. M. Reppert, and D. R. Weaver Targeted Disruption of the Mouse Mel1b Melatonin Receptor Mol. Cell. Biol., February 1, 2003; 23(3): 1054 - 1060. [Abstract] [Full Text]
|
|
|
|
|
|
M. I. Masana, S. Doolen, C. Ersahin, W. M. Al-Ghoul, S. P. Duckles, M. L. Dubocovich, and D. N. Krause MT2 Melatonin Receptors Are Present and Functional in Rat Caudal Artery J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 1295 - 1302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. D. Herzog and W. J. Schwartz Functional Genomics of Sleep and Circadian Rhythm: Invited Review: A neural clockwork for encoding circadian time J Appl Physiol, January 1, 2002; 92(1): 401 - 408. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
